drugset / Press release

New Indication Approved for Cervicitis for Yallaferon

2006-10-18 · Lee's Pharmaceutical Limited · original leespharm.com ↗

Recombinant Human Interferon a-2b · regulatory Recombinant Human Interferon α2b · regulatory Yallaferon® · regulatory

Yallaferon® ("Recombinant Human Interferon α-2b gel") has been approved for an additional indication for use in the treatment of cervicitis by the SFDA of China.This new approved indication offers an alternative therapeutic option for treatment of patients with cervicitis and cervical erosion.

The release as fetched from its publisher. leespharm.com ↗